Latest Revenue Generation News

Prairie Lithium is poised to begin commercial lithium production in Q4 2026 as its Direct Lithium Extraction facility nears completion, backed by a binding offtake agreement covering 100% of Phase 1 output and a strategic AU$10 million equipment contribution from Hydro Lithium.

IODM Limited has renewed its commercial agreement with Convera for the UK higher education sector, increasing its revenue share and shifting to a non-exclusive arrangement that broadens its market opportunities.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

Robex Resources Inc. has released its Q1 2026 production update, with Kiniero Gold Mine in Guinea producing 39,367 ounces of gold following commercial production commencement in February. The company’s cash and bullion holdings rose to US$255 million.

OzAurum Resources reports exceptional heap leach test results at Mulgabbie North, confirming rapid gold recovery and advancing a low-capex development strategy with near-complete plant refurbishment.

Since its October 2025 ASX IPO, Temas Resources has made significant strides in commercialising its proprietary metallurgical technology and advancing its Québec mineral projects, supported by solid financial reserves.

SportsHero Limited has secured a major content deal with Playades, adding over 400 popular mobile games to its HeroPlay platform and boosting subscriber growth in Southeast Asia ahead of the FIFA World Cup 2026.

Metallium Limited’s US subsidiary has inked a decade-long off-take agreement with Indium Corporation, setting a firm commercial foundation for supplying critical metals like gallium and germanium recovered through innovative recycling technology.

Papyrus Australia has commissioned its Adelaide Rapid Prototyping & R&D Facility, marking a key step in validating its pulp technology and progressing towards commercial production. The company also released its interim financials and reported stable cash flow supporting ongoing operations.

Cyclopharm Limited is rapidly expanding its Technegas® lung imaging technology across the US, securing new contracts and advancing clinical guideline recognition that could boost adoption.

WA Kaolin Limited has announced a partially underwritten pro-rata rights offer to raise up to $34.9 million, aiming to reduce debt and provide working capital to stabilise its Wickepin kaolin operations amid ongoing ASX suspension.